Boston, Dec. 9, 2021 – Dyno Therapeutics announced today that management is scheduled to participate at the Goldman Sachs Byte-ology Conference.
Dyno’s mission is to build the ideal capsid and solve the challenges of vivo gene delivery. Our data driven approach is a key enabler and differentiator. Dyno’s CapsidMap Platform is building the world’s most informative and diverse library of capsid measurements, and an algorithm that learns to efficiently explore sequence space in search of the best capsids for therapeutic delivery.
Tune in today at 11:00 ET to catch Eric Kelsic, CEO and co-founder: Click Here for Webcast